The effect of L-DOPA on the hypothalamic-pituitary-thyroid axis.
D000368:Aged; D005260:Female; D006801:Humans; D006885:Hydroxybutyrates / Q000627:therapeutic use; D007031:Hypothalamus / Q000187:drug effects*; D007980:Levodopa / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D010901:Pituitary Function Tests; D010902:Pituitary Gland / Q000187:drug effects*; D010903:Pituitary Gland, Anterior / Q000187:drug effects*; D013961:Thyroid Gland / Q000187:drug effects*; D013972:Thyrotropin / Q000378:metabolism; D013973:Thyrotropin-Releasing Hormone; D013974:Thyroxine / Q000378:metabolism; D013997:Time Factors; D014284:Triiodothyronine / Q000378:metabolism
D006885:Hydroxybutyrates; D014284:Triiodothyronine; D007980:Levodopa; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D013974:Thyroxine